Arabic Arabic English English French French German German
dark

FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose

The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Hemogenyx Pharmaceuticals PLC Announces Final Results

Next Post

FDA-funded report on compounded hormones is tainted, PCF-commissioned analysis shows

Related Posts
Total
0
Share